Journal Mobile Options
Table of Contents
Vol. 69, No. 1, 2002
Issue release date: July 2002
Section title: Original Paper
Urol Int 2002;69:33–35
(DOI:10.1159/000064357)

Brucellar Orchitis in Innerwest Anatolia Region of Turkey

A Report of 12 Cases

Kadikoylu G. · Tuncer G. · Bolaman Z. · Sina M.
Departments of aInternal Medicine, and bInfection Diseases, Adnan Menderes University Medical School, Aydin; cSandikli State Hospital, Department of Biochemistry, Afyon, Turkey

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 33.00
Account: USD 23.00

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: 7/8/2002

Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 1

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: http://www.karger.com/UIN

Abstract

Brucellosis, which affects the genitourinary system in rate of 2–20%, is a multiorgan infectious disease. Twelve patients were diagnosed as having brucellar orchitis serologically, clinically and ultrasonographically. In 2 patients, Brucella melitensis was isolated in blood cultures. All the patients were working in cattle dealing. They were treated with 600 mg/day rifampicin plus 200 mg/day doxycycline for 6 weeks and followed up during 1 year. They recovered clinically within 3 weeks. Although they did not have any symptoms or findings, in 4 patients, serological titers did not return to normal after 6 weeks. In 2 of these patients, relapse was seen in the 6th and 8th months, respectively. These 2 patients recovered with 1 g/day ciprofloxacin plus 2 g/day tetracycline for 6 weeks. Relapse did not occur again. Conclusively, brucellosis must be considered as a cause of orchitis in especially endemic regions where cattle dealing is widespread. The patients must be followed for relapse during at least 1 year.


  

Author Contacts

Y. Doç. Dr. Gürhan Kadıkoylu
Adnan Menderes Üniversitesi Tıp Fakültesi
İç Hastalıkları AD, TR–09100 Aydin (Turkey)
Tel. +90 256 2124078, Fax +90 256 2120146
E-Mail gurhan@medscape.com

  

Article Information

Received: Received: January 18, 2001
Accepted after revision: August 3, 2001
Number of Print Pages : 3
Number of Figures : 0, Number of Tables : 1, Number of References : 22

  

Publication Details

Urologia Internationalis
Founded 1955 by G. Peter A. Narath and Heinrich Heusser; Continued 1968–1987 by G. Mayor

Vol. 69, No. 1, Year 2002 (Cover Date: Released July 2002)

Journal Editor: D. Hauri, Zürich; M.P. Wirth, Dresden
ISSN: 0042–1138 (print), 1423–0399 (Online)

For additional information: http://www.karger.com/journals/uin


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: 7/8/2002

Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 1

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: http://www.karger.com/UIN


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.